Sort
21,281 grants matching “influenza”
Harnessing nutrition to enhance vaccine responses
$631,977Nicholas Collins · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · AI
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
$631,871Mark Joseph Mulligan · New York University School Of Medicine · UM1 · FY2023 · AI
University of Washington Vaccine and Treatment Evaluation Unit
$631,824Anna Wald · University Of Washington · UM1 · FY2020 · AI
Vaccine and Treatment Evaluation Units: Protocol Development and Implementation for a Phase I Influenza Vaccine Trial
$631,786Daniel Hoft · Saint Louis University · N01 · FY2019 · AI
Structure of the eukaryote transcription apparatus
$631,667Roger D Kornberg · Stanford University · R01 · FY2010 · AI
Human Vaccine Durability using Integrated Bioinformatics and a Novel in vitro Bone Marrow Mimic
$631,599Frances Eun-Hyung Lee · Emory University · U01 · FY2021 · AI
A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting
$631,554Gayani Tillekeratne · Duke University · R01 · FY2024 · AI
Large-scale production and purification of biological compounds
$631,190Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2012 · DK
Novel Influenza nano vaccines for broad cross protection
$630,929Baozhong Wang · Georgia State University · R01 · FY2021 · AI
Regulation of T cell homeostasis and memory
$630,664Linda Mac Pherson Bradley · Univ Of Massachusetts Med Sch Worcester · P01 · FY2010 · AI
Angiopoietin/Tie signaling regulation of vascular leakage in lung inflammation
$630,603Donald M McDonald · University Of California, San Francisco · R01 · FY2019 · HL
Synthetic Information Systems for Better Informing Public Health Policymakers
$630,550Stephen G Eubank · Virginia Polytechnic Inst And St Univ · U01 · FY2013 · GM
Forecasting tipping points in emerging and re-emerging infectious diseases
$630,489John M Drake · University Of Georgia · U01 · FY2015 · GM
Monocyte-derived alveolar macrophage drives inflammatory response to lung ozone exposure
$630,363Robert Matthew Tighe · Duke University · R01 · FY2022 · ES
Generation of antigen-specific regulation T cells
$630,324Harald Von Boehmer · Dana-Farber Cancer Inst · R37 · FY2010 · AI
Immune signatures of vaccine responses in children with sickle cell disease
$630,248Inci Burcin Yildirim · Yale University · R01 · FY2024 · AI
Respiratory Viruses and Airflow Obstruction after HCT
$630,159Fred Hutchinson Cancer Research Center · R01 · FY2005 · HL
Determinants of H. influenzae Virulence in Otitis Media
$630,017Lauren O Bakaletz · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · DC
Collaborative Research: IHBEM: The fear of here: Integrating place-based travel behavior and detection into novel infectious disease models
$629,785Nick W Ruktanonchai · Virginia Polytechnic Institute And State University · · FY2023 · MPS
Infectious Diseases/Basic Microbial Pathogenic Mechanisms
$629,751Daniel E Goldberg · Washington University · T32 · FY2013 · AI
Vaccine and Treatment Evaluation Units
$629,614Mark Joseph Mulligan · Emory University · N01 · FY2012 · AI
Supramolecular nanofiber vaccines
$629,583Joel H Collier · Duke University · R01 · FY2016 · AI
K-VAC: Kentucky Vaccinating Appalachian Communities
$629,515Marc T Kiviniemi · University Of Kentucky · R01 · FY2023 · MD
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$629,468John Jay Treanor · University Of Rochester · N01 · FY2018 · AI
Forecasting tipping points in emerging and re-emerging infectious diseases
$629,386John M Drake · University Of Georgia · U01 · FY2016 · GM